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ABSTRACT 
VERIFICATION PROCESS OF THE ST. JUDE MEDICAL ATRIAL FIBRILLATION 
IMPLANTABLE CARDIAC MONITOR DEVICE 
By: Jimmy Quoc Hy Duong 
 The St. Jude Medical SJM ConfirmTM Implantable Cardiac Monitor (ICM) is a 
small implantable device that is used to detect arrhythmias and stores the electrogram 
(EGMs) records for physicians to verify the arrhythmia.  The objective of this device is to 
provide physicians with the technology to monitor patients who are suspected of having 
arrhythmias but do not exhibit any symptoms of this heart condition.  This device allows 
for long term continuous monitoring of patients and provides recordings for physicians to 
prove the existence of an arrhythmia.  With the help of this device, doctors can make 
better decisions on determining what type of treatment patients would need and provide 
care for those who otherwise may be diagnosed too late.  
 The effort that goes into creating an ICM device is a strict and stringent process.  
The reason is to ensure that the device is of high quality.  The software itself is quite 
complicated and the verification of the software is critical.  Reviews of all verification 
test designs and test implementations are conducted to ensure complete coverage of 
software requirements.  As part of the submission process for approval of these devices, a 
traceability report of the requirements to passed test cases must be provided, along with 
evidence that the software poses no harm to the patient. 
 
 
Keywords: St. Jude Medical, Implantable Cardiac Monitor, Arrhythmias, Electrogram 
Records, Software Verification 
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I. INTRODUCTION 
Background on Atrial Fibrillation 
The Human Heart 
The human heart is a muscle that is made up of four chambers, each of which works 
together to circulate oxygenated blood from the lungs into all the parts of the body and 
also circulates oxygen depleted blood from the body into the lungs.  
 
Figure 1: Anatomy of a Human Heart and the flow of blood through the heart [1] 
In Figure 1, the pink and blue arrows illustrate the flow of blood through the anatomy of 
the human heart.  The pink arrow represents oxygenated blood, while the blue arrow 
represents deoxygenated blood.  This process begins when the atriums first relax, and 
then, deoxygenated blood enters the right atrium and oxygenated blood enters the left 
atrium.  Once the atrium chambers are filled, the muscle contracts and pumps the blood 
into its respective ventricles.   The atrium then relaxes and the chamber fills up with 
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blood again.  Likewise, the ventricles also contract once they are filled and thus push the 
blood out to either the lungs (right ventricle) or the rest of the body (left ventricle).  The 
sequence of this process is very well-timed where an adult sized heart can effectively 
move 2,000 gallons of blood through the body in a single day. 
 
Figure 2: Action Potential by Cardiac Region [2] 
The relaxation and contraction of the heart muscle is controlled through electrical 
impulses in the muscle of the wall. Figure 2 illustrates the key components that help the 
heart beat, along with their action potential [2].  The colors of the action potential are 
color coded with the paths that the electrical signal takes as is goes through the respective 
parts of the heart.  Within the heart, there is a natural pacemaker called the Sinoatrial 
(SA) node.  In figure 2, the green lines show the path of the electrical impulse that the SA 
node initiates through the atrial muscle.  As this electrical signal passes through each 
muscle cell, the muscle cell contracts, and this contraction squeezes blood through the 
atriums.  As the electrical signal travels down the pathways in the atriums, the signal 
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reaches the Atrioventricular (AV) node, which regulates the transmission of the signal 
into the ventricles and through the Purkinje fibers.  This signal contracts the muscle cells 
in the ventricles and squeezes blood into the body. 
 
Figure 3: Annotated Electrocardiogram 
Figure 3 illustrates a strip of an electrocardiograph with a series of QRS 
complexes.  Each QRS complex represents a single heart beat. The P-wave represents the 
contraction of the atriums, and the QRS or simply, the R-wave, represents the contraction 
of the ventricles.  Lastly, the T-wave represents the relaxation of the ventricles.   
A normal heart beat is classified as a Sinus rhythm. For an average adult, the heart at 
rest will beat about 60-80 beats per minute.  Each P-wave would be followed by an R-
wave.  
Arrhythmias 
When a heart rhythm is not regular, this arrhythmia can be classified into different 
categories.  Slow heart rate rhythms are classified as bradycardia while fast heart rhythms 
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are classified as tachycardia.  For the most part, bradycardia and tachycardia rhythms still 
have the basic shape of the QRS complex, just with different rate intervals.    
There are many things that can contribute to the cause of arrhythmias.  Some possible 
causes [3] are scarring of the heart tissue from a heart attack, heart disease, stress, alcohol 
abuse, caffeine, and hypertension.  Stimulants such as alcohol and caffeine can raise the 
heart rate, causing a mild tachycardia.  Scar tissue causes a disturbance in the electrical 
pathways, and the signal deflects in different directions instead of following the correct 
pathway.  This is also known as a re-entrant rhythm where the electrical impulse deflects 
in a different direction causing electrical impulses flowing in multiple directions.  This 
leads to fibrillation or flutter because the atriums can start to quiver uncontrollably due to 
the multiple sources of electrical impulses.  
Definition of Atrial Fibrillation 
When the atriums contract at fast abnormal rates, this condition is also known as 
Atrial Fibrillation (AF).  AF is a condition that affects about 2.2 million Americans and is 
projected to increase to 5.6 million Americans by the year 2050 [4]. 
AF is characterized with the condition where the atrial chambers quiver 
irregularly at rates often greater than 300 beats per minute.  Since AF occurs in the atrial 
chambers, it is possible that the ventricular chambers are beating at a normal rate, which 
means that AF can be asymptomatic.  Thus, by itself, AF is generally not life threatening. 
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Figure 4: ECG recording of Sinus Rhythm 
 
 
Figure 5: ECG recording of Atrial Fibrillation 
 Figure 4 provides an electrocardiogram recording of a normal sinus rhythm.  As 
you can see from the figure, each P wave has a corresponding QRS wave.  This implies a 
one-to-one pairing of the heart beats in the atrium to the ventricle chambers.  In Figure 5, 
this one-to-one pairing is non-existent.  There are many P waves for each QRS and this is 
classified as Atrial Fibrillation since the atrium is out of sync with the ventricles and is 
beating more rapidly and inconsistently than the ventricles. 
Symptoms of Atrial Fibrillation 
If left untreated, AF can lead to other serious conditions such as chronic fatigue and 
congestive heart failure.  If symptoms do present themselves, some of the common 
symptoms [5] are: 
Chest pain  
Decreased blood pressure 
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Dizziness/Lightheadedness  
Fainting (syncope) 
Palpitations, sensation of heart beating 
Shortness of breath  
Sweating  
Weakness and difficulty exercising  
It is possible for an individual to be asymptomatic, and this can be potentially hazardous 
since the individual may not be able to get help until it is too late.   
Diagnosing Atrial Fibrillation 
If symptoms are present, a doctor can easily diagnose a patient with AF and confirm 
this by collecting an electrocardiogram record.  But since AF can be asymptomatic and 
people can have spontaneous episodes at random times, this poses a higher degree of 
difficulty since a doctor might not be able to detect the arrhythmia while the patient is in 
the doctor’s office.  Without being able to get an electrocardiogram recording, the doctor 
can not verify or accurately diagnose a patient with AF.  So if the patient is not exhibiting 
any signs in the office, the doctor can only monitor the electrocardiogram recordings 
outside the office through a cardiac monitoring device.  These devices are portable and 
are relatively small, which allows patients to be monitored for an extended period of time 
outside of the doctor’s office.  Studies show that cardiac monitors diagnose arrhythmias 
in up to 88% of the cases studied, a percentage that is much higher that traditional 
methods [6].   
Some of the most common types of cardiac monitors are:  
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• Holter Monitors:  A holter monitor is a small external recorder that is worn for a 
short period of time, generally between one to three days.  Electrodes are placed 
on the chest and connected to the monitoring device.  Much like an EKG, these 
electrode patches record the electric impulses of the heart muscles.  
• Portable Event Monitors:  Patients who are symptomatic and have less frequent 
episodes may need a cardiac monitor that lasts longer.  Just like holter monitors, 
electrode patches are placed on the patient to capture the electrical signals.  These 
portable event monitors, however, need the user to initiate a recording whenever 
they feel the onset of symptoms. 
• Transtelephonic Monitors:  Transtelephonic Monitors are devices that also 
record the heart rhythm and transmits it to the doctor’s office over the telephone.  
Once the doctor receives the recordings, he or she can analyze the EGMs and 
verify if the patient indeed has AF.  This method provides a quicker turn around 
than the portable event monitors or holter monitors since the patient does not need 
to travel to the doctor’s office in order for the doctor to check if the device detects 
anything.  
The intent of these monitors is to provide continuous monitoring of the patient in the 
hopes that they can capture electrocardiogram recordings of anything substantial for the 
doctor to determine if the patient has AF or not. 
As helpful as these devices seem, there are still some major deficiencies with them.  
First, having external patches will cause some level of discomfort over time and will 
inconvenience a patient who wants to do certain activities such as swimming.  If a person 
is asymptomatic, they would also not know when to start the recording, and this may lead 
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to misdiagnosis.  There are also those individuals who may have infrequent AF episodes 
and would need a long-term monitoring device that would constantly record the heart 
rhythm.  
Treatment of Atrial Fibrillation  
There are three main treatments [7] for AF:  
a) medication to slow the heart down, 
b) electrical cardioversion to help regulate the heart beats, and 
c)  ablation of the muscle cells.   
Doctors use an assortment of medications to help control AF.  Drugs commonly 
used can range from beta blockers to blood thinners in the attempt to help control the 
heart rate and the heart rhythm.   
Electrical cardioversion [7] helps regulate the heartbeat through electrical shock, 
such as those created by a defibrillator.  This type of treatment aims at trying to reset the 
heart through the electrical shock to the chest or to the heart muscle.  If the patient suffers 
from long term AF, electrical cardioversion may not be as effective since they are likely 
to experience AF again after cardioversion.     
Ablation attempts to treat AF by removing or killing the muscle cells that are 
triggering the re-entrant nodes.  The doctor can perform a procedure to obtain a mapping 
of the electrical signals of the heart muscle cells and determine the location of the re-
entrant nodes.  The physician can then go and ablate that area so that the electrical 
pathways of the muscle cells return to normal.  
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St. Jude Medical SJM ConfirmTM Implantable Cardiac Monitor 
An Implantable Cardiac Monitor (ICM) is a cardiac monitoring device that is 
implanted subcutaneously in a patient to help capture electrocardiogram recordings of the 
heart beats and store them for a physician to review at a later time.  Since this device is 
implantable, it helps eliminate some of the deficiencies of an external cardiac monitor.  
This implantable device allows patients to maintain their level of quality of life.  Patients 
do not suffer from the discomfort of having to attach external patches to their skin, or the 
inconvenience of having to take off their monitoring device when they take a shower.   
An ICM provides continuous long-term monitoring, something that their external 
counterpart cannot provide.  
 
 
Figure 6: St. Jude Medical SJM ConfirmTM Implantable Cardiac Monitor 
The St. Jude Medical SJM ConfirmTM, seen above in figure 6, is an ICM that is 
implanted subcutaneously near the collar bone.  This ICM can be activated to start 
recording ECG signals by detecting specific heart rhythms, and it can also be activated by 
the patient through an external activator that is placed over the device.  The electrodes 
reside on the surface of the actual device, which makes this procedure less invasive since 
the device is leadless. 
The SJM ConfirmTM ICM device is intended for: 
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a) Patients with clinical syndromes or situations at increased risk of cardiac 
arrhythmias  
b) Patients who experience transient symptoms that may suggest a cardiac 
arrhythmia 
It is the smallest ICM on the market today at 6.5 cc, weighs 12 grams, and has longevity 
of three years.  The device can also store up to 48 minutes of EGM recordings, or 147 
episodes [8]. 
From a software perspective, the features implemented [9] on the device are: 
a) Detection of Tachycardia, Bradycardia, and Asystole Episodes 
b) Detection of Atrial Fibrillation Episodes 
c) Distinguishing the difference between noise, physical activity, and a 
tachycardia episode 
d) Compatibility with MerlinTM Patient Care System  
e) Patient-triggered activation option for EGM storage  
f) SenseAbility® technology for greater sensitivity  
g) Data storage options for flexibility 
h) Receipt of Vital Information through Extensive Data Reports  
i) Comprehensive diagnostic data to assist in patient management  
j) Trans-telephonic monitoring for timely and accurate data transmission  
 
The Trans-telephonic feature is also an interesting feature because it provides patients 
the ability to upload data collected by the implanted devices directly into a database from 
the comfort of their own home telephone system.  This is provided through the Patient 
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Activator, which is an external device that is used to trigger patient-activated recordings 
as well as download data from the SJM ConfirmTM ICM device to transfer it over the 
telephone system.  Thus, doctors can closely monitor their patients in a more effective 
and timely manner instead of having all their patients set up in-office appointments. 
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II. Objective of the Software Verification  
As the Software Verification Organization of a medical device company, our main 
goal is to ensure that our products are designed according to their specifications and most 
importantly, to ensure that the device is safe for patients and that all potential hazards are 
mitigated.   
Thus the software verification process [10] is a well-defined process with many 
checks and balances along the way to ensure that all conditions are properly handled.  
Software Verification Process 
 
Figure 7: Flowchart of the Software Verification Process 
The Software Verification Process consists of multiple phases.  In figure 7, the 
flowchart illustrates that the cornerstone of the verification process is the Software 
Requirements Specifications, also known as the SRS.  With these requirements in place, 
the verification engineers conduct test strategy meetings to plan the testing approach of 
verifying each requirement in the SRS.  Once a strategy is in place, the verification test 
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design and test implementation is created to ensure that the software meets all the 
requirements in the SRS.  All designs and implementations must go through a formal 
review, and once the documents are accepted testing of the device begins.  The testing 
portion of the flowchart consists of the Formal Runs.  According to the figure above, the 
detection of any issues in this phase requires a SWR and may require a re-test.  Once the 
Formal Runs are completed, the results are packaged as part of the submission packet to 
prove that the software is safe for human use and meets the specified requirements.  The 
last phase of the project cycle consists of the traceability report along with the software 
verification report. As you can see, each phase plays a critical role in producing a well-
tested product, and will be further detailed below.    
Software Requirement Specifications 
The SRS is the building block to the entire software development.  The SRS tries to 
detail the functional behavior of the product, but at the same time, it does not impose onto 
the developer a particular implementation.   Throughout the SRS, the document varies in 
complexity and style from feature to feature.  However, regardless of the style of the 
requirements, the goal of the SRS is to provide the software developers with the 
specifications on how to design the software code.  Independently, the software 
verification engineers design test cases to test the functionality of the software through 
these same requirements. This results in a double redundancy in which the 
implementation of the software and its testing goes through two separate processes.  If 
the verification test cases pass, this assures us that the software code was designed to the 
specifications described in the SRS.  Software verification engineers participate in 
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analyzing these requirements to make sure that they are complete, thorough, and also 
testable.   
Test Strategies 
After analyzing the SRS, the first step in the software verification process is to use the 
SRS to develop a test strategy that will help guide the software engineer in planning the 
test design.  Although test strategies are not required for every feature, it is highly 
recommended that new feature development, and features that are complex, should go 
through a phase of strategy planning.   
During this phase of testing, the tester studies the requirements and gains a general 
understanding of how to test their features.  The tester then organizes the different test 
scenarios using state diagrams, outlines, bullet points, or charts and tables.  After 
organizing this data, the tester holds a strategy workshop meeting to discuss the test 
strategy.  Individuals from other groups then provide assistance during this meeting to 
make sure that the test strategy is complete and that all the scenarios to fully test the 
requirements are identified. 
Test Designs 
After the test strategy review, the next phase is the test design which provides details 
regarding each test case.  Details are placed into each test case to describe the 
requirement coverage, the configuration parameters, the test setup, the sequence of steps 
in the test case, and the expected results.  This document, along with the requirements 
and test strategy, goes through a series of reviews.   
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Each test case indicates which requirements it covers and whether it is a positive 
coverage or a negative coverage.  A positive test case is a direct test, that the conditions 
of the requirement are met, proving the software performs what the requirement states.  A 
negative test case is an indirect test which performs conditions that should not invoke the 
requirement and verifies that this requirement is still met.   
Test Implementation 
After the test design, the test cases are then implemented using either the Unity Test 
Library (UTL) tool or the System for Making Automated and Random Tests (SMART) 
tool.  Both of these tools are designed by St. Jude Medical to assist in performing 
automated test verification.  The UTL tool is based on a C++ framework while the 
SMART tool is based on flow diagrams.  In addition to the actual test implementation, 
part of the test implementation phase is to import the test cases into our test repository 
system in order to facilitate scheduled test runs of the test implementation.  The software 
verification group uses an in-house tool called Software Automated Integrated Network 
Test System (SAINTS) for this purpose.  More details about each of the tools are given 
below in the Methods and Material section. 
Verification Test Review Process 
There are different types of reviews that take place in regards to the test strategies, 
test designs, and test implementations.  Informal reviews are optional while formal 
reviews are required for test designs and test implementations.  The main difference 
between the two reviews are that formal reviews go through a much stricter process, and 
this review is filed away in the Design History File for the project and is included in our 
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submission process.   Each review consists of a pre-review packet, an issues list, and also 
a post-review packet which contains all the corrections to the packet that were noted in 
the issue list [11]. 
Roles and Responsibilities 
In these review meetings, there are four different types of participants.  The 
Author is the creator of the document under review.  After the review, the author 
examines the issue list and makes all the appropriate changes to the document.  The 
Moderator is the individual who is responsible for making sure the review meeting stays 
on topic and maintains the flow of the review.  If discussions get lengthy, the moderator 
is responsible for making sure that the issue is noted.  The moderator is also required to 
verify that issues in the issue list are properly addressed.  If the moderator does not agree 
with a resolution to an issue, the author must go back and investigate this issue again.  
Only when the moderator is satisfied with the disposition of the issue, is the review 
considered complete.   The Recorder is the individual who collects all issues, questions, 
and concerns that are noted in a review and compiles it into an issue list.  Since the role 
of the recorder is only present during the actual meeting, it is possible that this person 
could have multiple roles such as author in addition to their role as recorder.  Lastly, there 
are also Key Reviewers who are responsible to ensure that the review has been 
thoroughly inspected and that they have intimate knowledge of the feature that is being 
reviewed.  Key reviewers can be engineers from the requirements, software development, 
and/or system engineering groups. 
Informal Reviews 
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An informal review is an internal review held among the software verification 
group.  The purpose of this meeting is to review the completed review packet, to catch 
minor and recurring issues, and to look for missing test scenarios and discrepancies 
between the SRS and the test design. This type of review is optional, but it is always 
encouraged because it can prevent engineers from other groups from having to sit 
through a review that is full of minor and obvious issues.  Although issues from this 
review are recorded, it is not necessary to track the resolution of the issues since these 
reviews are informal and are not part of our regulatory submission process. 
Formal Reviews 
 A formal review is mandatory for all test designs and test implementations.   All 
issues are recorded in the Review Database, and the moderator of the review verifies all 
resolutions in the issue list.  The review database helps keep track of issues and is used as 
a formal method to document that the outlined processes in our guidelines have been 
followed.  Formal Reviews that have too many issues may be changed to an Informal 
Review.   By doing so, this allows the author to go back and address all the issues instead 
of making massive changes which do not get reviewed by the extended group.  Once a 
Formal Review is accepted, the author then works on resolving all the issues that were 
noted.  The moderator then verifies that the resolution was correctly resolved before the 
review is considered complete. 
 After a formal review is complete, all the issues that arise are addressed and 
tracked through a Software Work Request (SWR) order.  The verification test designs 
and test implementations do not need to be reviewed again since the SWRs will 
document any changes. 
18 
 
Regression Runs 
Throughout the software development process, there are several internal software 
releases.  These internal software releases are iterative releases of key features in the 
product.  Breaking the feature set into subsets, allows the software verification group to 
start their test implementation phase prior to the final completion of the software 
development cycle.  With each internal software release, the features that are part of that 
subset go through a regression test.  As more features are added, so is the number of test 
cases that are added to the regression run.  The purpose of this is to ensure that with each 
release, which includes modifications and additional features, the software does not 
introduce new bugs.  The software verification team tests these releases and executes the 
most up-to-date set of test cases.  An additional benefit of running these regression tests 
is to provide a confidence in uncovering issues before the final run.  Issues uncovered by 
the regression runs can be filed against the actual software itself or with the verification 
test cases.  During this phase of the software test process, issues are reported to the 
respective groups so that they can be resolved in iterative releases of the software. 
Formal Run 
The Formal Run is the final test run that will have its results reported to the different 
regulatory agencies of each country in which the company is applying for approval of the 
device.  An example of such an agency is the US Food and Drug Administration (FDA).  
This final run is done at the very end of the project life cycle.  At this time, all 
requirements, software code, and software test cases have been formally reviewed.  The 
formal test run consists of the execution of the full software verification test cases on the 
final software code and also on the final hardware configuration.  Any issues or 
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discrepancies that arise during the formal test run require a SWR to be analyzed and 
disposed of properly.  Possible dispositions of a SWR may be: 
• to address the issue, which would led to a new release of software and a re-run of 
affected test cases, or  
• to postpone the issue if it is deemed to be non-critical and non-hazardous, or 
• to consider the SWR as a non-issue. 
The results of the Formal Test Run are stored into the test repository and these results are 
used to generate all the necessary reports. 
Master Verification Matrix Report 
Once all the test cases are either passing or have a SWR disposition of either 
postponed or non-issue, a Master Verification Matrix (MVM) report is generated.  The 
SAINTS tool generates the MVM report, which is used to provide a traceability report 
linking each requirement to a particular passing test case.  This is used to ensure that full 
coverage of the SRS was performed and that there are no missing test cases.  The MVM 
report lists all the feature names, with their associated number of test cases, number of 
manual test cases, number of test cases which passed, number of test cases which failed, 
number of test cases with errors, number of test cases with warnings, number of tests 
without any results, and any SWRs linked to the features.  Ideally, there should not be 
any test cases with failures, errors, warnings, or no results.  However, if there are, there 
needs to be an associated SWR that describes the discrepancy, and this SWR must be in a 
terminal state as described above. 
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Software Verification Report 
Finally, the final phase of the software verification process is the Software 
Verification Report (SVR).  The SVR is a report that is generated to document the entire 
testing results.  It is submitted to the different agencies when applying for approval of the 
device.  The results that get reported in this document are the test results from the Formal 
Run along with the results from the MVM report. 
The SVR lists all the feature names, with their associated Test Design Document 
name, test design baseline version, firmware version that was used for testing, and the 
pass/failure result.  In addition to this, the SVR also includes a summary of the test 
results, a list of the issues and the corresponding SWR, and a statement that the 
verification test results demonstrate that the testing of the firmware requirements have 
been met and that there are no known significant issues in terms of patient safety or 
clinical efficacy.  This statement indicates that the software version has successfully met 
the qualification requirements for human clinical use. 
Design History File  
The Design History File (DHF) is the centralized file system that stores all the final 
documents for a project.  This repository consists of all plans, reviews, and final 
documents from all the different groups.  These documents are the signed-off formal 
copies of the review packets, plans, and reports.  Each item has an item number that is 
used to reference that particular document.  In previous projects, the DHF was a physical 
file cabinet that held hard copies of these documents, but presently, these documents are 
stored electronically in an online database. 
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III. Methods and Material 
SAINTS 
Software Automated Integrated Network Test System [12], also known as the 
SAINTS tool, provides a system to run automated tests and also provides detailed reports 
about the status of test runs.  This tool was originally designed for the purpose of 
allowing individuals the ability to log into this system and run test cases from their own 
computer and distribute the execution of the test cases over a network of test stations that 
are controlled by the SAINTS tool.  However, as the tool matured, it took on more roles, 
such as adopting the ability to create test designs.  Previously, test designs were created 
and maintained in a Microsoft Word document.  Since the SAINTS tool has knowledge 
of each test case, a test designer was developed within the SAINTS tool to replace the 
older Microsoft Word documents.  This Test Designer provided the verification engineer 
the ability to create new test cases and populate the following fields for each test case: 
- Description of the objective of the test case 
- Requirement coverage 
- Test Procedure with expected results  
Since SAINTS has knowledge of the requirements for each test case, the execution of the 
test case, and the results of the test case, the MVM reporting tool was also added to the 
SAINTS tool.   
In regards to test execution, the SAINTS tool reduced the time it took to run test cases 
since the tool itself acted as a database where testers would be able to schedule test runs 
on stations that were available through the SAINTS tool.  This meant that more time 
could be spent on analyzing results than having to manually schedule test runs.  Also, by 
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combining all the test stations into a pool, this allowed for multiple testers to share a 
subset of custom test stations. 
The SAINTS tool also provided real-time result reporting, execution results, test 
station availability, and MVM reports instantaneously since all these components were 
integrated into the SAINTS tool. 
Unity Test Library 
The verification test cases were then implemented using the Unity Test Library 
(UTL).  The UTL is a collection of C++ system function calls that serves as an interface 
between the verification test cases and the software code.  This method falls more in line 
with the typical software testing methodology and uses the C++ programming language 
in developing the test cases.  These test cases would be linear test cases which provide 
some input conditions and pass and fail criteria through verification points in the code 
that a particular output has occurred. 
Testers using this approach code C++ test scripts that execute commands on the test 
stations.  An example of such commands is to generate a heart beat on the Heart 
Simulator to follow a particular pattern.  Using the test library functions, the test script 
would then monitor if the software code on the device performs as specified by the 
software requirements.  If these status checks are met, the test library would report a 
success, but if a certain time elapses, the test would be marked as a failure. 
SMART 
The System for Making Automated and Random Tests (SMART) tool [14] was 
another in-house tool that was designed as an alternative to traditional test designs and 
implementations though C++ test scripts. The ultimate goal of the SMART tool was to 
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combine the test design phase with the test implementation phase of the verification 
cycle.  Combining the test design phase with the implementation phase optimized the 
testing approach and met the needs of a tool for easy maintenance across different 
projects as well as different iterations of the same project. 
 
Figure 8: Sample SMART Test Case 
The SMART tool has two components – the SMART Test Designer and the 
SMART Test Engine.  The SMART testing methodology is centered on test designs that 
consist of a set of state diagrams, as shown above in figure 8.  Using the SMART Test 
Designer, the tester constructs the state diagram by laying out the desired states and the 
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transition paths between states.  Thus, the general flow of the test case would be to start 
at the initial state and then take a particular transition path when events occur until the 
test either reaches a success state or a failure state.  The state diagram approach allows 
for multithreaded test designs as more than one state diagram can be executed at a given 
time.  The SMART Test Engine optimizes the verification testing cycle by taking these 
same state diagrams and executing them on the test station, thus combining the test 
design and test implementation phases together.  Another benefit of using the state 
diagram approach is that it allows for others who may not have a strong computer 
programming background, such as biomedical engineers, to be contributors to the 
software verification group. 
SMART State Diagram 
The basic structure of the state diagrams that make up the Test Design is composed of 
the following different states: 
• Initial State 
• Ordinary State 
• Decision State 
• Failure State  
• Success State 
 
Figure 9: Initial State 
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The Initial State, seen in figure 9 above, is the origin of a particular test design.  In 
a single test flow, there is only one Initial State and it is where the test begins.  This state 
is represented by a black-filled circle. 
 
Figure 10: Ordinary State 
The Ordinary State, seen in figure 10 above, may or may not contain an action 
item in it.  Action items can consist of setting values to variables, programming 
parameters, or generating heart rhythms.   This state is represented by a rectangle. 
 
Figure 11: Decision State 
The Decision State, seen in figure 11 above, contains expressions.  Depending on 
the outcome of those expressions, a particular decision path will be taken as the result 
directs the flow of the test case in that direction.  The decision state is represented as a 
diamond. 
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Figure 12: Failure State 
The Failure State, seen in figure 12 above, is a terminal state that indicates a 
particular test case has failed.  This state is represented by red circles with an X in it. 
 
Figure 13: Success State 
Conversely, the Success State, seen in figure 13 above, indicates that a particular 
test case has passed.  This state is represented by green circle with a check mark in it.  
SMART vs. Unity Test Library 
The SMART and UTL verification tools were both available for the SJM ConfirmTM 
ICM project, also known as the AFM 1.0 Firmware project.  As a software organization, 
we were looking at ways to streamline our testing, and this led us to decide upon a single 
test methodology for the Software Verification Organization.  An objective of the AFM 
1.0 Firmware project was to evaluate the different testing methodologies that existed at 
that time and to determine the direction that the Software Verification Organization 
would follow for future projects.  There were other ongoing projects that were already 
using the UTL approach but the Software Verification Organization had yet to implement 
test cases using the SMART approach.   
During planning for the feature testing of the AFM 1.0 Firmware project, the test 
features were divided into two groups – one group using the UTL approach and the other 
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group using the SMART approach.  The test engineer assigned to each feature 
determined which testing approach to use.  At the completion of the project, we 
compared the two tools based on these criteria: 
- Did the tools ensure a high level of quality in the software? 
- How did the two tools compare in terms of time it took to develop a test case? 
- How easy was it to maintain the same test cases so that they can be reused for 
future releases? 
Comparison Between the Two Tools 
At the completion of the Software Verification phase of the AFM 1.0 Firmware 
project, the Software Verification Organization held a summit to review the results [14] 
of the SMART vs. UTL evaluation.  For the AFM 1.0 Firmware project, there were 29 
different test features consisting of the following: 
- 12 features used the SMART test implementation method 
- 13 features used the UTL testing method 
- 1 feature used a combination of both testing methods   
Breaking this down further, there were 301 test cases developed in SMART and 184 test 
cases developed in UTL (note 18 test cases were manual test cases and were not counted 
in this total). 
The first criterion that we discussed was the level of quality of the two 
approaches.  To evaluate the level of quality, the number of defects/SWRs filed against 
the software, the requirements, and the verification test cases was counted.  The UTL 
approach recorded 47 SWRs, and the SMART approach recorded 41 SWRs.  These 
figures were pretty close and indicated that overall the SMART tool performed similarly 
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to the UTL tool in terms of SWRs.  This indicated that each method verified the software 
without any major differences in the number of defects, thus showing that both tools 
fared evenly for this first criterion. 
The second criterion dealt with improving the development time it takes to 
implement a project.  There were differences in the test features that were developed 
using the SMART tool and the UTL tool and their level of difficulties, as well as 
differences in the verification engineer’s skill level and level of familiarity with the 
features.  Unless we were able to take two equally skilled engineers and give them the 
same feature to develop test cases – one using the SMART tool and one using the UTL 
tool – it would be hard to evaluate this criterion because there is no real “apples to 
apples” comparison to determine which test method was faster in developing test cases.   
Because the UTL approach separates the design and implementation into two separate 
phases there is more potential for human error since the traceability between Test Design 
to Test Implementation is a manual process.  There is a slight advantage to the SMART 
approach given that there are fewer reviews since the test design and implementation are 
combined.   
Lastly, in the area of maintainability, the goal here was to determine how easy it 
would be to reuse test cases from one software release to the next. This is important 
because in between each software code release there needs to be some changes done by 
the testing tools to accommodate for changes to the software code.  This maintainability 
criterion evaluated the speed in which it tools to be ready for regression test runs.  In 
terms of the SMART tool, the SMART Tools Team generally can have it ready for 
testing within a few minutes after the new software code is released.  The Verification & 
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Validation (V&V) Library Team performs the updates to the UTL, and it generally takes 
a few minutes to a day to get the UTL ready for testing after the new software code is 
released.  Although there seems to be quite a difference in preparation time for the two 
tools, the V&V Library Team explained that the that they were able to generally have a 
turnaround of a few minutes too, but due to a lack of understaffing, had to pushes the 
release out the next day.  So the actual amount of time it took for the V&V Library Team 
and the SMART Tools Team to make the changes to release and update the tool was 
about even.  So this criterion ended up equal between the two tools.   
Conclusion of the Evaluation 
At the Software Verification Organization summit, the results of the evaluation 
between the SMART and UTL tools from the AFM 1.0 Firmware project were published 
[14].  The SMART tool provided some benefits over the UTL tool since it cut down the 
development time by combining the Test Design phase with Test Implementation phase.  
The SMART test cases also found similar and comparable issues as those found in the 
UTL test cases.  However, after analyzing the results of the comparison, the overall 
objective of streamlining the verification process indicated that future verification 
projects should migrate to the UTL methodology since 3 other projects were already 
using this approach.  Although the SMART tool was proven to be a viable substitute to 
the UTL tool, the foreseeable projects were already using the UTL test methodology, so 
there was no reason for the Software Verification Organization to continue using the 
SMART methodology.  
30 
 
IV. Results 
The software verification portion of the SJM ConfirmTM ICM project started in May 
of 2007 and concluded with the submission of the project to the FDA in May of 2008.  
The SJM ConfirmTM ICM device received FDA approval four months later in September 
of 2008, and by the end of that year, there were well over 800 implants of this device 
[15].   
Leading a group of 10 engineers, the team successfully executed the software 
verification for the SJM ConfirmTM ICM device.  Throughout this process there were 
milestones defined by the Software Verification Organization which helped track the 
completion of the project and helped ensure that the software requirements were 
thoroughly tested and that the device was safe for human use.  These milestones included 
the test strategies, the test designs, the test implementations, and the test result report.  
Upon the completion of the project, all the individual components of each milestone were 
placed into the DHF, and these documents signaled the completion of the development 
phase of this project. 
Master Verification Matrix Report 
Table 1: AFM 1.0 Firmware Master Verification Matrix Report  
P/N – 40005718 Rev. A 
 
Feature 
Test 
Cases 
Manual 
Test 
Cases 
Total 
Pass Fail Error Warning No Result SWRs 
ACTD 12 2 12 0 0 0 0   
AFD 65 2 65 0 0 0 0   
BAQ 5 0 5 0 0 0 0   
CC 7 0 7 0 0 0 0   
Conn 63 3 63 0 0 0 0   
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Feature 
Test 
Cases 
Manual 
Test 
Cases 
Total 
Pass Fail Error Warning No Result SWRs 
Diag 20 0 20 0 0 0 0   
Diag_AF 26 4 26 0 0 0 0   
Diag_LT 5 0 5 0 0 0 0   
Disc 19 0 19 0 0 0 0   
EGM 58 0 58 0 0 0 0   
FSDT 17 0 17 0 0 0 0   
IE 25 0 25 0 0 0 0   
IS 6 0 6 0 0 0 0   
MDbm 10 2 10 0 0 0 0   
MDsat 8 0 8 0 0 0 0   
MED 20 0 20 0 0 0 0   
Mrkr 10 0 10 0 0 0 0   
NSE 13 1 13 0 0 0 0   
Prog 10 0 10 0 0 0 0   
Rst 7 1 7 0 0 0 0   
SC 20 1 20 0 0 0 0   
SO 8 0 8 0 0 0 0   
TBA 27 1 27 0 0 0 0   
Tel 32 1 32 0 0 0 0   
UED 10 0 10 0 0 0 0   
  
503 18 503 0 0 0 0 Note: All SWRs 
were 
determined 
by CCB to 
have no 
effect on 
patient safety 
or clinical 
efficacy 
 
From above, Table 1 is the MVM report [16] summary from the AFM 1.0 Firmware 
project.  This report lists out each feature in column one of the table and then lists the 
following information for that feature in the subsequent columns: 
- Total number of test cases 
- Number of manual test cases 
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- Number of passed test cases 
- Number of failed test cases 
- Number of test cases with errors  
- Number of test cases with warnings 
- Number of test cases without any results, and 
- SWRs that were filed during the formal run. 
For example, for Activity Detection (ACTD) there were 26 total test cases with 4 of them 
being manual test cases.  The rest of the columns beside the PASS column are zero or 
empty, which indicates that all 26 test cases passed without any issues.  From Table 1, the 
total number of test cases executed in AFM 1.0 Firmware project is 503, with 18 of them 
designated as manual test cases.  During Test Design reviews, test cases identified to be 
difficult to test are classified as manual test cases and are covered by firmware bench or 
unit testing.  Many times these requirements are corner cases or scenarios that are 
difficult to generate on the test stations.  As a result, manual test cases were created in 
order to achieve 100% coverage of software requirements.  So in total there were 485 
automated test cases in AFM 1.0 Firmware project. 
Table 2: AFM 1.0 Requirements Traceability Report 
P/N – 40005718 Rev. A 
 
Feature Requirements Test Coverage Pass Fail Error Warning No Result 
ACTD 36 36 36 0 0 0 0 
AFD 52 52 52 0 0 0 0 
BAQ 23 23 23 0 0 0 0 
CC 3 3 3 0 0 0 0 
Conn 19 19 19 0 0 0 0 
Diag 1 1 1 0 0 0 0 
Diag_AF 80 80 80 0 0 0 0 
Diag_LT 8 8 8 0 0 0 0 
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Feature Requirements Test Coverage Pass Fail Error Warning No Result 
Diag_SUM 55 55 55 0 0 0 0 
Diag_TBAM 16 16 16 0 0 0 0 
Diag_VHR 15 15 15 0 0 0 0 
Disc 6 6 6 0 0 0 0 
EGM 145 145 145 0 0 0 0 
FSDT 5 5 5 0 0 0 0 
IE 16 16 16 0 0 0 0 
IS 5 5 5 0 0 0 0 
MD 10 10 10 0 0 0 0 
MDbm 38 38 38 0 0 0 0 
MDsat 13 13 13 0 0 0 0 
MED 33 33 33 0 0 0 0 
Mrkr 35 35 35 0 0 0 0 
NSE 36 36 36 0 0 0 0 
Prog 9 9 9 0 0 0 0 
Rst 92 92 92 0 0 0 0 
SC 19 19 19 0 0 0 0 
SO 10 10 10 0 0 0 0 
TBA 109 109 109 0 0 0 0 
Tel 14 14 14 0 0 0 0 
UED 10 10 10 0 0 0 0 
 
In addition to the MVM summary report [16], table 2 above displays the requirement 
coverage traceability report of each feature.  This report lists all the features in AFM 1.0 
Firmware project in column one of the table and then lists the following information for 
each feature in the subsequent columns: 
- Total number of requirements in the SRS 
- Number of requirements covered 
- Number of passed requirements 
- Number of failed requirements 
- Number of requirements with errors  
- Number of requirements with warnings, and 
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- Number of requirements without any results. 
For example, for Atrial Fibrillation Detection (AFD) there were 52 total requirements in 
the SRS.  All 52 requirements are covered by test cases that passed formal runs.  In total 
there were 913 requirements for the AFM 1.0 Firmware project.   
Software Verification Report 
The Software Verification Report [17] for the AFM 1.0 Firmware project was signed 
off on April 29th, 2008.  This report documented the results of the final test run on the 
final software code.  The Software Verification Organization reported that all test 
requirements were covered with passing test cases.  The report also found that there were 
zero software-related issues found during the final run.  These results prompted the 
completion of the software verification portion of AFM 1.0 Firmware project.    
35 
 
V. Conclusion 
The SJM ConfirmTM ICM project was a highly successful project.  It was the first 
cross-divisional project in SJM that leveraged the technology from the pacemaker and 
ICD platforms to develop a device that entered a whole new market.  This device 
increased St. Jude Medical’s portfolio by providing a minimally invasive diagnostic 
device.  This device allows physicians to monitor individuals continuously and then 
determine if they need further treatment such as a pacemaker, defibrillator, or ablation.   
AFM 1.1 
Due to the popularity of the SJM ConfirmTM ICM, work on the next software release 
of this device has already been completed and submitted to the FDA.  The changes from 
the first release were minimal, and focused mainly in the area of improving the 
algorithms for detection and the storage of EGM records.  Many of these enhancements 
were based off data from actual devices that were implanted in patients.   
For the AFM 1.0 Firmware project, the sensing technology with the electrodes on the 
surface of the device was new.  So after the initial release of the device, the software 
developers optimized the detection algorithms for the AFM 1.1 Firmware project using 
actual data collected from patients.     
Patient data also indicated that there were a few instances where too many episodes 
were recorded due to the over detection of noise.  Once the device detected the 
occurrence of noise, it ended the current arrhythmia episode recording because the noise 
detection considered the rhythm a false detection.  This was ending the episode recording 
too early.  Once the detection of noise ended, the arrhythmia would be detected again, 
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and this would trigger a new episode recording.  As a result, this cycle increased the 
number of episodes recorded by the device, leading to a potential of lost episode records 
when the memory of the device filled up before the doctor got a chance to analyze it. 
Future Work 
Improvements are constantly part of the lifespan of any product.  In fact, 
improvements are necessary in order to stay competitive in this type of market.  The 
future of the SJM ConfirmTM ICM is very broad, and future aspirations can be classified 
into the following major categories which are all somewhat dependent on each other:  
- Performance and power efficiency 
- Additional features 
- Increased memory for storage 
For future releases the performance and power improvements can be made to both the 
hardware and software components.  An example of this type of improvement is with 
battery efficiency.  Improving the battery efficiency allows for a longer longevity of the 
device as well as the ability to support more sensor features or even radio frequency 
communication to the device.  Also, from a software standpoint, code optimization would 
free up some memory which can be in turn used to increase the amount of EGM records a 
device can store.     
Improving the performance and power efficiencies of the device will allow for 
improvements of additional software features.  Many of these algorithms are already exist 
in SJM pacemakers and implantable cardiac defibrillators (ICDs).  Features that may be 
in the pipeline are the addition of Radio Frequency (RF) communication, Morphology 
Scoring, and Exercise Compliance.  Improvements to the battery efficiency will allow for 
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the RF communication while preserving the longevity of the device.  RF communication 
allows for more frequent data collection via a bedside monitor without the knowledge of 
the patient, thus improving the quality of life.  In addition to RF, other potential features 
are algorithms to help improve the detection of certain heart rhythms in order to better 
filter out muscle and external noise.  One such feature used by ICDs is the detection 
algorithm called Morphology Scoring.  The concept behind this algorithm is to use the 
shape of a normal heart rate as a template and compare each heart beat to this template.  
If the shape of the heart rate is not a close match, it helps to indicate that either there is 
noise or that the patient is in an arrhythmia.  Another algorithm that can be migrated over 
is Exercise Compliance.  This algorithm detects if a patient is exercising by monitoring 
the heart rate over a period of time.  If exercise is detected, the algorithm will choose to 
ignore tachycardia rhythms (fast rhythms) and not record these since they are expected 
due to the exercise.   
Lastly, increasing the physical memory on these devices will provide the user with 
the ability to store even more records.  This allows doctors to retrieve even more 
episodes.  More memory would also allow for other diagnostic data, such as body 
temperature or respiration rate, to be collected too.   More information being captured 
allows for more data, which could potentially help develop new algorithms or 
improvements to current algorithms.      
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